RIEDEL NORBERT G (CIK 1161662) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Sell JAZZ (1,692 shares), Sell JAZZ (14 shares), Buy JAZZ (1,605 shares), Buy ETON (12,500 shares), Buy ETON (19,655 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,692 | $408,432 |
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 14 | $3,425 |
| 2026-08-07 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 1,605 | $0 |
| 2026-04-22 | Eton Pharmaceuticals, Inc. (ETON) | Director | Buy | 12,500 | $91,375 |
| 2026-04-22 | Eton Pharmaceuticals, Inc. (ETON) | Director | Buy | 19,655 | $169,230 |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,415 | $471,543 |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 3,415 | $655,680 |
| 2026-02-05 | Eton Pharmaceuticals, Inc. (ETON) | Director | Buy | 30,000 | $132,600 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,805 | $200,806 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02